Filing Details
- Accession Number:
- 0001209191-16-156108
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-12-20 16:15:44
- Reporting Period:
- 2016-12-16
- Filing Date:
- 2016-12-20
- Accepted Time:
- 2016-12-20 16:15:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
908259 | Mateon Therapeutics Inc | MATN | Biological Products, (No Disgnostic Substances) (2836) | 133679168 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1687930 | Rogers Donald Reynolds | C/O Mateon Therapeutics, Inc. 701 Gateway Blvd., Suite 210 South San Francisco CA 94080 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $.01 Par Value Per Share | Acquisiton | 2016-12-16 | 12,700 | $0.34 | 12,700 | No | 4 | P | Direct | |
Common Stock, $.01 Par Value Per Share | Acquisiton | 2016-12-16 | 7,350 | $0.35 | 20,050 | No | 4 | P | Direct | |
Common Stock, $.01 Par Value Per Share | Acquisiton | 2016-12-16 | 9,950 | $0.36 | 30,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |